Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
John Butler is recorded as CEO at Nacco Industries Inc (NC) and CEO, CFO and Board Member at Akebia Therapeutics, Inc. (AKBA). The proxy statement of Akebia Therapeutics, Inc. reports total compensation of $5,652,339 for John Butler in fiscal 2025, including a base salary of $864,010. Disclosed compensation is on record for 5 fiscal years. John Butler has spoken on 27 earnings calls and 1 other investor event across 2 companies, most recently for Akebia Therapeutics, Inc. on August 5, 2026.
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2024-03-22–present
2013-01-01–present
Recorded roles and call appearances connecting this person to public companies.
CEO, CFO, Board Member
2013-01-01–present
Other people whose current roles at this company are on record from its filings.
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Akebia Therapeutics, Inc. (AKBA) | CEO | $864,010 | $5,652,339 |
| 2024 | Akebia Therapeutics, Inc. (AKBA) | CEO | $833,966 | $4,260,114 |
| 2023 | Akebia Therapeutics, Inc. (AKBA) | CEO | $795,723 | $2,775,123 |
| 2022 | Akebia Therapeutics, Inc. (AKBA) | CEO | $765,118 | $3,072,538 |
| 2021 | Akebia Therapeutics, Inc. (AKBA) | CEO | $718,430 | $3,133,316 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
